ARCHIVES

Adherez Issued U.S. Patent for Catenin Molecule Inhibition.

This article is from The Cancer Letter archive.

Vol. 29 No. 27 | July 4, 2003

Download PDF Visit The Full Archive

Related Articles

Give Young Women Data, Not Guidelines, Advisors Tell NCI; consensus For Over 50

October 29, 1993

NCI-Approved Clinical Trials

July 30, 2004

Sixty CCOPs Could cost $16 Million; DCPC Staff Believes They Can Get It

October 10, 1986

MD Anderson Survey Shows Faculty Dissatisfaction with Top Leaders

May 23, 2014

“We’d Ban Cigarettes’ If Nicotine Were a Drug, FDA Commissioners Says

February 14, 1992

The First BRCA1 Test Hits The Market; Are Oncologists, Patients Ready?

January 26, 1996